翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378）于2026年5月14日发布公告，披露于当日于香港联交所场内回购股份事宜。
根据公告，公司当日回购2.78万股普通股H股，占现有已发行股本约0.02%，回购价格区间介乎每股29.46港元至32港元，合共支付价格总额838,548港元（约83.85万港元）。本次回购完成后，公司已发行股本变动为135,592,430股，同时库藏股数量增至626,400股，合计股本数仍为136,218,830股。
公司股东于2026年2月12日通过购回授权，授权总数为13,621,883股。此前公司已合计回购626,400股，占购回授权通过当日已发行股本总数的约0.4598%。公司确认已遵守香港联交所证券上市规则及相关法律法规的规定。
本公告由公司董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.